 PureTech Health LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF PLC and Nektar Therapeutics NASDAQ:NKTR said they have mutually agreed to terminate discussions regarding a possible combination of the two companies. The talks were first announced on 7 October 2022 in response to press speculation. 